Document is current
Any future updates will be listed below
-
Authors
Goto, Shinichi https://orcid.org/0000-0002-0450-0331
Mahara, Keitaro
Beussink-Nelson, Lauren
Ikura, Hidehiko
Katsumata, Yoshinori
Endo, Jin https://orcid.org/0000-0001-7770-2519
Gaggin, Hanna K.
Shah, Sanjiv J. https://orcid.org/0000-0002-5655-8201
Itabashi, Yuji
MacRae, Calum A.
Deo, Rahul C. https://orcid.org/0000-0002-2791-9434
- License Information
-
More Information
Article History
Received: 9 July 2020
Accepted: 23 December 2020
First Online: 11 May 2021
Competing interests
: R.C.D is supported by grants from the National Institute of Health, the American Heart Association (One Brave Idea, Apple Heart and Movement Study) and GE Healthcare, has received consulting fees from Novartis and Pfizer, and is co-founder of Atman Health. S.J.S. is supported by grants from the National Institutes of Health (R01 HL140731, R01 HL120728, R01 HL107577, and R01 HL149423); the American Heart Association (#16SFRN28780016, #15CVGPSD27260148); Actelion, AstraZeneca, Corvia, and Novartis; and has received consulting fees from Actelion, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Cardiora, Eisai, Ionis, Ironwood, Merck, Novartis, Pfizer, Sanofi, and United Therapeutics. C.A.M. is a consultant for Pfizer and co-founder of Atman Health. All other authors declare no competing interests.
